Overall survival in advanced hepatocellular carcinoma treated with concomitant systemic therapy and stereotactic body radiation therapy or systemic therapy alone

Overall survival in advanced hepatocellular carcinoma treated with concomitant systemic therapy and stereotactic body radiation therapy or systemic therapy alone

IntroductionFirst-line systemic therapy (ST) options for advanced hepatocellular carcinoma (HCC) include tyrosine kinase inhibitors and immunotherapy (IO). Evolving data suggest prolonged overall survival (OS) when ST is combined with stereotactic body radiation therapy (SBRT), although evidence is...

Full description

Bibliographic Details
Main Authors: Alexander Piening, Anand Swaminath, John Dombrowski, Ryan M. Teague, Noor Al-Hammadi, Jeevin Shahi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Oncology
Subjects:
systemic therapy
stereotactic body radiation therapy
stereotactic radiosurgery
hepatocellular carcinoma
survival outcomes
retrospective analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1290691/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1290691/full

Similar Items